arrow
J

Julian Philipp Layer

University of Bonn
H指数:11
被引数:547

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic impact of blood group O in MGMT-methylated glioblastoma patients receiving radiochemotherapy with temozolomide and lomustine

O血型在MGMT甲基化胶质母细胞瘤患者接受替莫唑胺和洛莫司汀放化疗中的预后影响

2026-09-240
OAAI
Core2Edge: a human glioblastoma organoid–brain slice model capturing infiltration and transcriptional heterogeneity from core to single-cell dispersion

Core2Edge:一种捕获从核心到单细胞分散的浸润和转录异质性的人类胶质母细胞瘤类器官-脑片模型

2026-07-280
PRE
Outcome and safety of SBRT in centrally and ultra-centrally located lung tumours: A PRISMA-based systematic review and Meta-Analysis

SBRT治疗中央型及超中央型肺肿瘤的疗效与安全性:一项基于PRISMA的系统评价和Meta分析

2026-05-230
OA
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial

基于L-RNA适配体的CXCL12抑制联合放射治疗和贝伐珠单抗在 newly-diagnosed glioblastoma 中的研究:扩展I/II期GLORIA试验

2026-04-080
OA
Radiotherapy-induced abscopal effects in immune checkpoint inhibitor-refractory metastatic disease: results from a large multicenter real-world cohort study
2026-01-220
PRE
Evaluating the efficacy and immunological impact of combined ICIs and SBRT in HCC: A narrative literature review

评估ICIs和SBRT联合治疗肝癌的疗效和免疫学影响: 叙述性文献综述

2026-01-110
OAAI
Histological and molecular characterization of endolymphatic sac tumor reveals key differences from its primary differential diagnosis, choroid plexus papilloma

内淋巴囊肿瘤的组织学及分子学特征揭示其与主要鉴别诊断——脉络丛乳头状瘤存在关键差异。

2025-12-010
PRE
Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastoma

酰胺质子转移加权(amide proton transfer-weighted, APTw)磁共振成像在IDH野生型胶质母细胞瘤伪进展单时间点诊断中的临床常规应用

2025-11-130
OAAI
Effective and safe use of immune checkpoint inhibitors for non-small cell lung cancer in people living with HIV

人类免疫缺陷病毒感染者中非小细胞肺癌免疫检查点抑制剂的疗效与安全性应用

2025-11-050
OAAI
The impact of ASC expression and NLRP1 inflammasome signaling in glioblastoma

ASC表达和NLRP1炎症小体信号在胶质母细胞瘤中的影响

2025-11-010
PRE
The GLIOSCREEN trial: Feasibility, genomic landscape, and clinical impact of prospective comprehensive molecular profiling in newly diagnosed glioma

GLIOSCREEN试验:前瞻性全面分子分型在 newly diagnosed glioma 中的可行性、基因组景观及临床影响

2025-11-010
OAAI
DUAL INHIBITION OF POST-RADIOGENIC REVASCULARIZATION IN NEWLY-DIAGNOSED GLIOBLASTOMA: FINAL RESULTS OF THE MULTICENTRIC PHASE 1/2 GLORIA TRIAL

放射后新生血管生成的双重抑制在新诊断胶质母细胞瘤中的应用:多中心GLORIA试验1/2期最终结果

2025-11-010
OAAI
Decision-making between DCA and VMAT in Linac-based SRS for brain lesions: A dosimetric analysis based on tumor size and geometry and introduction of Qasym
2025-10-210
OAAI